COMMUNIQUÉS West-GlobeNewswire

Life Line Screening Offers Blood Test That May Provide Early Insight Into Alzheimer’s Disease Risk
02/09/2026
A simple blood test that measures an Alzheimer’s-related biomarker may help adults 55 and older decide whether further evaluation is appropriate, even before symptoms appear INDEPENDENCE, Ohio, Sept. 02, 2026 (GLOBE [...]
The Cost of Loneliness Project Announces a Journey Across America Leading to the First National Day of Connection on Nov. 12
02/09/2026
Founder Lucy Rose begins Walk With Me, a two-month journey through more than 45 communities in 17 states, calling on every American to join a new national tradition: Take 12 at 12 on Nov. 12 WINSTON-SALEM, N.C., Sept. [...]
Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
02/09/2026
SANDWICH, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class clinical-stage treatment for osteoarthritis (OA), today [...]
NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy
02/09/2026
Collaboration will use NewBiologix’s Xcell™ platform to establish a scalable manufacturing foundation for Synastra’s investigational DMD gene therapy program LAUSANNE, Switzerland, Sept. 02, 2026 (GLOBE NEWSWIRE) -- [...]
DoKegel Launches Personalized Pelvic Floor Training App for Men
02/09/2026
New DoKegel App Turns a Short Quiz Into a Daily Kegel Routine NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- DoKegel has launched a men's wellness app built around personalized Kegel exercises. The app pairs guided pelvic [...]
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
02/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“ CDT ” or the “ Company ”) today announced that, following the recent issuance of shares and the exercise of [...]
Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer
02/09/2026
Dr. Røpcke joins Resalis with extensive experience in clinical drug development as well as expertise in obesity and cardiometabolic therapy areas Torino, Italy, September 2, 2026 – Resalis Therapeutics , a biotechnology [...]
Wolverine Stack: Kylo Peptides Introduces New BPC-157 and TB-500 Research Combination
02/09/2026
Sheridan, Wyoming, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides has introduced the Wolverine Stack [ https://kylopeptides.com/product/wolverine-stack/ ] to its research catalog, supplying BPC-157 and TB-500 as two [...]
IBA rejoint l’initiative européenne PFAROS pour accélérer le développement de solutions de destruction des PFAS dans les secteurs de la santé et de la pharmacie
02/09/2026
Louvain ‑ la ‑ Neuve, Belgique, le 2 septembre 2026, 7h00 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélérateurs de particules, annonce aujourd’hui sa participation à PFAROS, [...]
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
02/09/2026
Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research [...]
Nicox annonce l’extension de son horizon de trésorerie
02/09/2026
Communiqué de presse Nicox annonce l’extension de son horizon de trésorerie Position de trésorerie de 8.4 millions d’euros 1 au 31 août 2026 , suffisante pour financer les opérations actuelles au-delà du 1er trimestre [...]
Nicox Announces Extension of Cash Runway
02/09/2026
Press Release Nicox Announces Extension of Cash Runway Cash position, of €8.4 million 1 as of 31 August 2026, sufficient to fund existing operations beyond Q1 2028 NCX 470 U.S. NDA approval milestone would fund [...]
Novonesis to build next generation enzyme production facility in India
02/09/2026
Novonesis will invest €600 million to expand its site in  Patalganga  and build a state-of-the-art facility. This marks another step in the company's long-term growth strategy and continued investment in its global [...]
Desert Hope Treatment Center Addresses Community Need for Increased Addiction Services with New Virtual Program
02/09/2026
LAS VEGAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment provider in Las Vegas, has added a virtual intensive outpatient treatment program to its array of care services. [...]
Acquisition of Own Shares
01/09/2026
Mechelen, Belgium; 01 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic [...]
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
NEW HAVEN, Conn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas” or the “Company”), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly- [...]
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
01/09/2026
FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be [...]

Pages